Skip to content

Outcomes of Veno Arterial ECMO

In-hospital Mortality of Patients With Veno Arterial ECMO: a Prospective Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05155904
Acronym
ECMOCARD
Enrollment
150
Registered
2021-12-14
Start date
2021-11-16
Completion date
2026-11-30
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extra Corporeal Membrane Oxygenation, Mortality

Keywords

veno arterial, mortality, extra corporeal membrane oxygenation

Brief summary

veno arterial (VA) extra corporeal membrane oxygenation (ECMO) is a rescue therapy with various indications including refractory cardiac arrest and refractory cardiogenic shock. Amiens hospital university has an ECMO program and is a regional center to address patients requiring VA ECMO. In spite of the application of international guidelines, the mortality of patients with VA remains high with an admitted survival rate at hospital discharge at 40%.

Interventions

None listed

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age : ≥ 18 * Patient with a VA ECMO

Exclusion criteria

* age\<18

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortalityUp to hospital discharge, an average of 1 monthIn-hospital mortality of patients with : veno arterial (VA) extra corporeal membrane oxygenation (ECMO)

Countries

France

Contacts

Primary ContactOsama Abou Arab, MD
abouarab.osama@chu-amiens.fr03 22 08 78 36

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026